Literature DB >> 29444986

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.

Ian Woolhouse1, Lesley Bishop1, Liz Darlison2, Duneesha De Fonseka3, Anthony Edey4, John Edwards5, Corinne Faivre-Finn6, Dean A Fennell7, Steve Holmes8, Keith M Kerr9, Apostolos Nakas10, Tim Peel11, Najib M Rahman12, Mark Slade13, Jeremy Steele14, Selina Tsim15, Nick A Maskell16.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29444986     DOI： 10.1136/thoraxjnl-2017-211321

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  35 in total

Review 1.  Extended pleurectomy decortication: the current role.

Authors:  Rocco Bilancia; Marco Nardini; David A Waller
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 2.  Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

Authors:  Charlotte De Bondt; Ioannis Psallidas; Paul E Y Van Schil; Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2018-10

3.  The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?

Authors:  David A Waller
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 4.  Use of Immune Checkpoint Inhibitors in Mesothelioma.

Authors:  Patrick M Forde; Arnaud Scherpereel; Anne S Tsao
Journal:  Curr Treat Options Oncol       Date:  2019-02-14

Review 5.  A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).

Authors:  Jo Raskin; Veerle Surmont; Robin Cornelissen; Paul Baas; Paul E Y van Schil; Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2018-10

6.  Advances in pulmonary and pleural malignant disorders.

Authors:  Jack A Kastelik; Angshu Bhowmik; John Park
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

7.  What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey.

Authors:  Selma Metintas; Guntulu Ak; Emine Dundar; Muzaffer Metintas
Journal:  Int J Clin Oncol       Date:  2022-04-21       Impact factor: 3.402

8.  Managing malignant pleural mesothelioma: experience and perceptions of health care professionals caring for people with mesothelioma.

Authors:  Anne Warby; Haryana M Dhillon; Steven Kao; Janette L Vardy
Journal:  Support Care Cancer       Date:  2019-01-25       Impact factor: 3.603

9.  Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.

Authors:  Rachelle Asciak; Nikolaos I Kanellakis; Xuan Yao; Megat Abd Hamid; Rachel M Mercer; Maged Hassan; Eihab O Bedawi; Melissa Dobson; Peter Fsadni; Stephen Montefort; Tao Dong; Najib M Rahman; Ioannis Psallidas
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

Review 10.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.